Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Book Closure For The Purpose Of Payment Of Dividend For The Financial Year Ended 31St March, 2019, And The AGM

 We hereby inform you that the 31st Annual General Meeting (AGM) of the Company shall be held on Friday, 20th September, 2019. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 14th September, 2019 to Friday, 20th September, 2019 (both days inclusive) for the purpose of payment of dividend for the financial year ended 31st March, 2019, and the AGM.
13-08-2019
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

 We wish to inform you that the Board of Directors have appointed Ms. Madhumita Ganguli (DIN - 00676830) as an Additional Director of the Company. A brief profile of Ms. Madhumita Ganguli is enclosed. This is for your information and records.
30-07-2019
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Unaudited Financial Results For Quarter Ended 30Th June, 2019

 Enclosed please find a copy of the Unaudited Financial Results for the quarter ended 30th June, 2019, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3:00 pm and ended at 5.00 p.m. This is for your information and record.
26-07-2019
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended June 30, 2019

 Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
20-07-2019
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30-06-2019

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 26th July, 2019, to consider and approve, the unaudited financial results for the quarter ended 30th June, 2019.
12-07-2019
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 031310 Name of the Signatory :- AJAY KUMAR SINGHALDesignation :- Company Secretary and Compliance Officer
10-07-2019
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that the Company has followed adequate procedure for transfer/dematerialisation of shares and has defaced and cancelled all the certificates for dematerialised shares for the quarter ended 30th June, 2019. This is for your information and record.
09-07-2019
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st July, 2019 till 48 hours after the declaration of financial results for the quarter ending 30th June, 2019. This is for your information and record.
29-06-2019
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

 We wish to inform you that Mr. Ashok Bajpai (DIN - 02463754) has resigned from the position of Managing Director of the Company due to personal reasons, effective from the close of the business hours on 15th June, 2019. This is for your information and records.
15-06-2019
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the provisions of Regulation 39 of the the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that we have received requests from the shareholders for issue of duplicate share certificates in lieu of share certificates reported lost, as per details enclosed.
17-05-2019
Next Page
Close

Let's Open Free Demat Account